Sign In
Buy ZSAN
$0.110
-0.0088 (-7.40%)
At Close: Sep 27, 2022
ZSAN Stock Price: Over 30% Increase Pre-Market Explanation
06:37am, Thursday, 27'th May 2021
The stock price of Zosano Pharma Corp (NASDAQ: ZSAN) increased by over 30% pre-market. This is why it happened.
FREMONT, Calif., May 26, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that an article titled, “Long Term Safety, Tol
Zosano Appoints Industry Veteran, Kathy McGee, to its Board of Directors
04:05pm, Tuesday, 25'th May 2021
FREMONT, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the appointment of Kathy McGee, an accomplished
Zosano Pharma Reports First Quarter 2021 Financial Results
04:05pm, Wednesday, 12'th May 2021
FREMONT, Calif., May 12, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the first quarter ended Ma
Zosano Pharma: Early PK+Safety Study In Q3 2021 May Breathe New Life Into This Biotech
07:30am, Friday, 30'th Apr 2021
Zosano Pharma: Early PK+Safety Study In Q3 2021 May Breathe New Life Into This Biotech
3 Penny Stocks to Watch During the Last Week of April
09:33am, Monday, 26'th Apr 2021
As April comes to an end, are these 3 penny stocks worth watching? The post 3 Penny Stocks to Watch During the Last Week of April appeared first on Penny Stocks to Buy, Picks, News and Information | P
7 Reddit Penny Stocks to Buy for a Biotech Boom
01:52pm, Friday, 16'th Apr 2021
So, which biotech penny stocks, popular with the Reddit set, offer such opportunity? Consider these seven as ones with potential to live up to online enthusiasm.
7 Reddit Penny Stocks to Keep Your Eye on for Big Movement
01:07pm, Wednesday, 24'th Mar 2021
Reddit stocks -- and in particular Reddit penny stocks -- are some of the riskiest shares out there. Yet, investors could make out big with some of the names on this list.
Zosano Pharma to Present at the H.C. Wainwright Global Life Sciences Conference
08:30am, Tuesday, 02'nd Mar 2021
FREMONT, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its president and chief executive officer,
Zosano Pharma Confirms NDA Resubmission Strategy Following Type A Meeting Minutes from FDA
08:30am, Monday, 22'nd Feb 2021
FREMONT, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that the company has received the official Type
ZSAN Stock: 9 Things to Know About Zosano Pharma as Shares Fly Higher
10:09am, Tuesday, 09'th Feb 2021
Zosano Pharma (ZSAN) stock is flying high on Tuesday with heavy trading despite there being a lack of news about the company. The post ZSAN Stock: 9 Things to Know About Zosano Pharma as Shares Fly Hi
ZSAN Stock Price Increased Over 100% This Past Week: Why It Happened
08:00am, Tuesday, 09'th Feb 2021
The stock price of Zosano Pharma Corp (NASDAQ: ZSAN) increased by over 100% this past week. This is why it happened.
Zosano Pharma Presents Early-Onset of Action Data for Qtrypta™ in Acute Treatment of Migraines
08:30am, Monday, 01'st Feb 2021
FREMONT, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that early onset of action data for Qtrypta™,
Zosano Pharma Requests Type A Meeting with the FDA to Review Resubmission Plans for Qtrypta™ New Drug Application
04:05pm, Monday, 04'th Jan 2021
FREMONT, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that on December 30, 2020 the company requested
Zosano Pharma to Present at the H.C. Wainwright Virtual BioConnect Conference
08:30am, Monday, 04'th Jan 2021
FREMONT, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its president and chief executive officer,
